OMEMI.

Trial name or title	Omega‐3 fatty acids in elderly patients with myocardial infarction trial (OMEMI)
Methods	RCT
Participants	Elderly patients (70‐82 years) with acute MI
Interventions	Each for 24 months: Arm 1: omega‐3 capsules, 3/d (Pikasol, total of 1.8 g/d EPA + DHA) and standard therapy Arm 2: corn oil placebo, 3/d and standard therapy
Outcomes	Primary: composite of total mortality, first non‐fatal recurring acute MI, stroke and revascularisation Secondary: new onset atrial fibrillation, adipose tissue, serum fatty acids, makers of endothelial function, inflammation, coagulation and fibrinolytic activity, genes associated with atherothrombosis
Starting date	Registered on Trials Registry: 16 April 2013 Trial start date: November 2012 Trial completion date est: November 2019
Contact information	Svein Solheim, Center for Clinical Heart Research, Oslo University Hospital, arnljot.tveit@vestreviken.no
Notes	NCT01841944